| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 232 | 57 | 93 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 232 | 57 | 93 | | | Operating Expenses | | Research Development | 17,808 | 19,937 | 13,600 | | Selling General and Administrative | 8,296 | 7,927 | 7,154 | | Non Recurring | 866 | 783 | 709 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (26,738) | (28,591) | (21,371) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,239) | 3,692 | 2,565 | | Earnings Before Interest And Taxes | (28,977) | (24,899) | (18,805) | | Interest Expense | 110 | 124 | 143 | | Income Before Tax | (29,087) | (25,023) | (18,948) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (29,087) | (25,023) | (18,948) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (29,087) | (25,023) | (18,948) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($29,087) | ($25,023) | ($18,948) |
|
0.06% Nasdaq 
Income Statement
